Tumor necrosis factor-alpha (TNF-α) inhibitors represent an effective treatment for severe
psoriasis in hepatitis C virus (HCV) patients. The literature reports mainly on short-term …

The treatment of severe psoriasis in patients with concomitant hepatitis-C virus infection is
quite difficult because several systemic anti-psoriatic drugs are contraindicated owing to …

Up to date, in literature, it is still debated the role of anti-tumor necrosis factors (TNF)-α
treatments in hepatitis C virus (HCV) patients. TNF-α performs a lot of functions, it is an …

Abstract Treatment of severe psoriasis in HCV positive patients is challenging, because
several psoriasis medications have a toxic effect on the liver, and interferon alpha, used to …

Background There is still relatively limited data on psoriasis and hepatitis C virus (HCV)
infections. Objective This study investigated the clinical characteristics and treatment of …

BACKGROUND: Treating psoriasis in patients with concomitant hepatitis C virus (HCV)
infection presents a special challenge. Not only is psoriasis exacerbated by interferon …

Treatment of patients with psoriasis and concomitant hepatitis-C virus (HCV) infection poses
a therapeutic challenge because most systemic drugs are associated with potential …

Patients with psoriasis and concomitant hepatitis C virus (HCV) infection present a
therapeutic challenge. The treatment of choice for HCV infection, interferon-α (IFN-α), might …

Patients with psoriasis and chronic hepatitis C virus (HCV) infection are a therapeutic
challenge. Systemic psoriasis treatment with methotrexate and acitretin can be hepatotoxic …

Introduction Tumour necrosis factor (TNF)‐α antagonists are effective for the treatment of
plaque‐type psoriasis and psoriatic arthritis, but concerns remain about the safety of these …